DDAH1 and breast carcinoma: Contrary results have been reported for prostate [41] and breast cancers [42], in which DDAH1 was overexpressed in cell lines with aggressive phenotype and its knockout resulted in inhibition of cell migration, implicating the enzyme in breast and pancreatic cancer invasion and metastasis [42,43].